These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1532519)

  • 1. Crossover design in pharmacy research.
    Cody RL; Slack MK
    Ann Pharmacother; 1992 Mar; 26(3):327-33. PubMed ID: 1532519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of alternative statistical models for crossover studies to demonstrate caffeine adjuvancy in the treatment of tension headache.
    Koch GG; Amara IA; MacMillan J
    J Biopharm Stat; 1994 Nov; 4(3):347-410. PubMed ID: 7881452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and analysis issues for crossover designs in phase I clinical studies.
    Boon PC; Roes KC
    J Biopharm Stat; 1999 Mar; 9(1):109-28. PubMed ID: 10091913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
    Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
    Int J Evid Based Healthc; 2005 Jul; 3(6):147-67. PubMed ID: 21631747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-efficient higher-order crossover designs in comparative bioavailability studies.
    Zhou J; Yuan Y; Reynolds R; Raber S; Li Y
    Clin Pharmacokinet; 2006; 45(6):623-32. PubMed ID: 16719543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-period crossover trials.
    Matthews JN
    Stat Methods Med Res; 1994 Dec; 3(4):383-405. PubMed ID: 7889228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crossover and self-controlled designs in clinical research.
    Louis TA; Lavori PW; Bailar JC; Polansky M
    N Engl J Med; 1984 Jan; 310(1):24-31. PubMed ID: 6689736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On assessment of bioequivalence under a higher-order crossover design.
    Chow SC; Liu JP
    J Biopharm Stat; 1992; 2(2):239-56. PubMed ID: 1300216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bayesian analysis of the two-period crossover design for clinical trials.
    Grieve AP
    Biometrics; 1985 Dec; 41(4):979-90. PubMed ID: 3830262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical approaches for design and analysis of clinical trials of infertility treatments: crossover designs and the Mantel-Haenszel method are recommended.
    Takada M; Sozu T; Sato T
    Pharm Stat; 2015; 14(3):198-204. PubMed ID: 25776032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
    Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
    JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical and research quality of the medical and pharmacy literature.
    Thorn MD; Pulliam CC; Symons MJ; Eckel FM
    Am J Hosp Pharm; 1985 May; 42(5):1077-82. PubMed ID: 4003419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis combining parallel and crossover trials using generalised estimating equation method.
    Curtin F
    Res Synth Methods; 2017 Sep; 8(3):312-320. PubMed ID: 28585280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal and/or Efficient Two treatment Crossover Designs for Five Carryover Models.
    Gondaliya J; Divecha J
    Int J Biostat; 2018 Nov; 14(2):. PubMed ID: 30471221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and analysis of crossover trials for absorbing binary endpoints.
    Nason M; Follmann D
    Biometrics; 2010 Sep; 66(3):958-65. PubMed ID: 19930189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crossover trials with a cumulative response.
    Walter SD
    J Biopharm Stat; 1997 Nov; 7(4):649-66. PubMed ID: 9358336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of two-treatment, two-period crossover trials in emergency medicine.
    Reed JF
    Ann Emerg Med; 2004 Jan; 43(1):54-8. PubMed ID: 14707941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal and efficient crossover designs under different assumptions about the carryover effects.
    Hedayat AS; Stufken J
    J Biopharm Stat; 2003 Aug; 13(3):519-28. PubMed ID: 12921398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crossover designs in lower extremity wounds.
    Reed JF
    Int J Low Extrem Wounds; 2003 Sep; 2(3):158-63. PubMed ID: 15866840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crossover experiment for clinical trials.
    Brown BW
    Biometrics; 1980 Mar; 36(1):69-79. PubMed ID: 7370374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.